Addleshaw Goddard advised Genedrive on the transaction. Genedrive, an AIM-listed near molecular diagnostics company, has received commitments to raise £7 million through the issue of 8,750,000…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Paolo Bossi
…
This content is for Standard 1 Year members only. LoginJoin Now